Pralidoxime Toxicity

Pralidoxime Toxicity is a clinical pharmacological condition characterized by adverse physiological effects arising from excessive or prolonged exposure to pralidoxime, distinguished from other antidote-related toxicities by its specific cholinesterase reactivator-induced neurotoxic and hepatotoxic manifestations.

54

Publications

1.4K

Citations

209

Authors

95

Institutions

Publications per year

2017–2026

3

Authors

209

  1. GP
    Georg Petroianu

    United Arab Emirates University, United Arab Emirates

    5 publications · 183 citations

    5

    h-index

  2. SM
    Syed M. Nurulain

    United Arab Emirates University, United Arab Emirates

    4 publications · 159 citations

    4

    h-index

  3. FJ
    Frédéric J. Baud

    Université Paris Cité, France

    3 publications · 43 citations

    3

    h-index

  4. PH
    Pascal Houzé

    Université Paris Cité, France

    3 publications · 43 citations

    3

    h-index

  5. KK
    Kamil Kuča

    University of Hradec Králové, Czechia

    3 publications · 169 citations

    3

    h-index

1–5 of 209

Venues

  1. PubMed

    Repository · 10 publications · 277 citations

    10

    h-index

  2. Human & Experimental Toxicology

    7 publications · 172 citations

    7

    h-index

  3. Journal of Toxicology Clinical Toxicology

    4 publications · 149 citations

    4

    h-index

  4. Journal of Applied Toxicology

    4 publications · 171 citations

    4

    h-index

  5. Toxicology Letters

    3 publications · 95 citations

    3

    h-index

1–5